Russia is all set to register its second coronavirus vaccine on October 15, 2020.
Vector State Research Center of Virology and Biotechnology, states this on Friday October 9, 2020.
The vaccine developer said the experimental vaccine has recently completed its early stage of human trials.
A statement released by the developer stated that, “The Healthcare Ministry of the Russian Federation began the procedure of registration of the EpiVacCorona vaccine.
“The completion of the registration procedure of the EpiVacCorona vaccine is planned by October 15, 2020,”
The Vector Research Center obtained the Russian Health Ministry’s permit to conduct clinical trials of its vaccine on volunteers in July.
The first volunteer was injected with the vaccine on July 27. The final group of 20 volunteers was discharged from the medical facility on September 8.
Russia’s chief sanitary doctor Anna Popova said, “The clinical trials have been very successful. The volunteers are developing the necessary titers and no one has any clinical signs after the vaccine – neither temperature nor any other reaction,”
The drug maker has announced that it will begin Phase III trials in November-December with nearly 30,000 volunteers taking part in post-registration trials of the coronavirus vaccine.
The vaccine will then be manufactured on the industrial site of the Vector research center.
“After the vaccine’s registration the centers of carrying out post-registration trials will be selected, and 30,000 volunteers will take part in them,” the statement said.
“There are not many such vaccines in the world, which are being developed by the Vector Center. This is a rather complicated process,” Popova said.